Search research articles
Contact Us
Filters
Showing results (71-80 of 202) with videos related to
Page
of 21
Sort By:
Urology
|
March 18, 2008
Clinical model of cost of bladder cancer in the elderly
Catherine D Cooksley, Elenir B C Avritscher, H Barton Grossman, et al.
Urology
|
September 2, 2014
Intravesical tumor involvement of the trigone is associated with nodal metastasis in patients undergoing radical cystectomy
Robert S Svatek, Timothy N Clinton, Clark A Wilson, et al.
Urologic Oncology
|
January 9, 2025
Concomitant antihistamine administration is associated with improved survival outcomes in patients with locally advanced or metastatic urothelial carcinoma treated with atezolizumab. Analysis of individual participant data from IMvigor210 and IMvigor211
Giuseppe Fallara, Federico Belladelli, Daniele Robesti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2007
Matrix metalloproteinase polymorphisms are associated with bladder cancer invasiveness
A Karim Kader, Jun Liu, Lina Shao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2005
Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival
Dan Leibovici, H Barton Grossman, Colin P Dinney, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
April 1, 2010
Energy balance, the PI3K-AKT-mTOR pathway genes, and the risk of bladder cancer
Jie Lin, Jianming Wang, Anthony J Greisinger, et al.
Cancer
|
August 24, 2012
A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results
Arlene O Siefker-Radtke, Colin P Dinney, Yu Shen, et al.
World Journal of Urology
|
June 12, 2021
Impact of sex on response to BCG in non-muscle invasive bladder cancer patients: a contemporary review from a tertiary care center
Kelly K Bree, Patrick J Hensley, Nathan Brooks, et al.
BJU International
|
November 30, 2021
Reduced-dose bacillus Calmette-Guérin (BCG) in an era of BCG shortage: real-world experience from a tertiary cancer centre
Niyati Lobo, Kelly K Bree, Patrick J Hensley, et al.
Plos One
|
June 16, 2012
Association of polymorphisms in oxidative stress genes with clinical outcomes for bladder cancer treated with Bacillus Calmette-Guérin
Hua Wei, Ashish Kamat, Meng Chen, et al.
Page
of 21
Search research articles
Search
Showing results (71-80 of 202) with videos related to
Sort By:
Page
of 21
Urology
|
March 18, 2008
Clinical model of cost of bladder cancer in the elderly
Catherine D Cooksley, Elenir B C Avritscher, H Barton Grossman, et al.
Urology
|
September 2, 2014
Intravesical tumor involvement of the trigone is associated with nodal metastasis in patients undergoing radical cystectomy
Robert S Svatek, Timothy N Clinton, Clark A Wilson, et al.
Urologic Oncology
|
January 9, 2025
Concomitant antihistamine administration is associated with improved survival outcomes in patients with locally advanced or metastatic urothelial carcinoma treated with atezolizumab. Analysis of individual participant data from IMvigor210 and IMvigor211
Giuseppe Fallara, Federico Belladelli, Daniele Robesti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2007
Matrix metalloproteinase polymorphisms are associated with bladder cancer invasiveness
A Karim Kader, Jun Liu, Lina Shao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2005
Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival
Dan Leibovici, H Barton Grossman, Colin P Dinney, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
April 1, 2010
Energy balance, the PI3K-AKT-mTOR pathway genes, and the risk of bladder cancer
Jie Lin, Jianming Wang, Anthony J Greisinger, et al.
Cancer
|
August 24, 2012
A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results
Arlene O Siefker-Radtke, Colin P Dinney, Yu Shen, et al.
World Journal of Urology
|
June 12, 2021
Impact of sex on response to BCG in non-muscle invasive bladder cancer patients: a contemporary review from a tertiary care center
Kelly K Bree, Patrick J Hensley, Nathan Brooks, et al.
BJU International
|
November 30, 2021
Reduced-dose bacillus Calmette-Guérin (BCG) in an era of BCG shortage: real-world experience from a tertiary cancer centre
Niyati Lobo, Kelly K Bree, Patrick J Hensley, et al.
Plos One
|
June 16, 2012
Association of polymorphisms in oxidative stress genes with clinical outcomes for bladder cancer treated with Bacillus Calmette-Guérin
Hua Wei, Ashish Kamat, Meng Chen, et al.
Page
of 21